Track Abbott Laboratories — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Abbott Laboratories ABT.VI · Stock Open Abbott Laboratories in new tab

96.18 EUR
P/E
36.29
EPS
2.65
Yield
2.21%
P/B
3.80
ROE
10.58
Beta
0.58
Loading chart...
Key Metrics
P/E36.29
EPS2.65
Book Value25.30
Price to Book3.80
Debt/Equity63.21
% Insiders0.495%
Growth
Revenue Growth0.13%
Earnings Growth-0.48%
Dividend
Dividend Yield2.21%
Annual dividends2.18 EUR
Ex-Div. DateJuly 15, 2026
Payout78.96%
5y avg Yield1.85%

DCF Valuation

Tweak assumptions to recompute fair value for Abbott Laboratories (ABT.VI)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Abbott Laboratories Logo Abbott Laboratories Analysis (ABT.VI)

United States Health Care Official Website Stock

Is Abbott Laboratories a good investment? Abbott Laboratories (ABT.VI) is currently trading at 96.18 EUR.

In terms of valuation, the stock trades at a P/E ratio of 36.29. This high multiple suggests investors have priced in significant future growth expectations.

For income investors, Abbott Laboratories pays a dividend yield of 2.21%. With a payout ratio of 79%, the dividend appears to be under pressure.

Investor FAQ

Does Abbott Laboratories pay a dividend?

Yes, it pays an annual dividend of 2.18 EUR (2.21% yield).

What asset class is Abbott Laboratories?

Abbott Laboratories is classified as a Stock. You can compare it against 12 other assets in the "Related Symbols" list on this page.

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Exchange Ticker
NYQ (United States) ABT
SGO (Chile) ABTCL.SN
SGO (Chile) ABT.SN
GER (Germany) ABL.DE
MEX (Mexico) ABT.MX
FRA (Germany) ABL.F
VIE (Austria) ABT.VI
BUE (Argentina) ABT.BA
MIL (Italy) ABT.MI
SAO (Brazil) ABTT34.SA
STU (Germany) ABL.SG
EBS (Ireland) ABT.SW
Trades
Dividend Yield
2.21%
5y avg 1.85%
Annual Dividends
2.18EUR
Next Ex. Div Date
July 15, 2026
Payout Ratio
78.96%
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
2027
1.81 EUR
July 14, 2027 (estimated) 0.6027
April 12, 2027 (estimated) 0.6027
Jan. 14, 2027 (estimated) 0.6027
2026
2.19 EUR
Oct. 12, 2026 (estimated) 0.5644
July 15, 2026 0.5408
April 15, 2026 0.5408
Jan. 15, 2026 0.5408
2025
2.03 EUR
Oct. 15, 2025 0.5065
July 15, 2025 0.5065
April 15, 2025 0.5065
Jan. 15, 2025 0.5065
2024
1.89 EUR
Oct. 15, 2024 0.4721
July 15, 2024 0.4721
April 12, 2024 0.4721
Jan. 11, 2024 0.4721
2023
1.75 EUR
Oct. 12, 2023 0.4378
July 13, 2023 0.4378
April 13, 2023 0.4378
Jan. 12, 2023 0.4378
2022
1.61 EUR
Oct. 13, 2022 0.4034
July 14, 2022 0.4034
April 13, 2022 0.4034
Jan. 13, 2022 0.4034
2021
1.55 EUR
Oct. 14, 2021 0.3863
July 14, 2021 0.3863
April 14, 2021 0.3863
Jan. 14, 2021 0.3863
2020
1.24 EUR
Oct. 14, 2020 0.3090
July 14, 2020 0.3090
April 14, 2020 0.3090
Jan. 14, 2020 0.3090
2019
1.10 EUR
Oct. 11, 2019 0.2747
July 12, 2019 0.2747
April 12, 2019 0.2747
Jan. 14, 2019 0.2747
2018
0.24 EUR
Oct. 12, 2018 0.2404
Upcoming Dividends
Name Payment Date Status Amount
Abbott Laboratories Jul 15, 2026 0.540792 EUR
Abbott Laboratories Apr 15, 2026 0.540792 EUR
Abbott Laboratories Jan 15, 2026 0.540792 EUR
Abbott Laboratories Oct 15, 2025 0.506456 EUR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion